dapsone has been researched along with Bladder Cancer in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with aggressive bladder cancer had a similar distribution but significantly lower mean value (p < 0." | 5.29 | Low activity of dapsone N-hydroxylation as a susceptibility risk factor in aggressive bladder cancer. ( Adedoyin, A; Branch, RA; Fleming, CM; Kaisary, A; Persad, R; Porter, J; Smith, P; Wilkinson, GR, 1994) |
| "Thirty-eight bladder cancer cases and 43 controls from these factories were included for study of acetylation phenotype, by dapsone administration, and for polymorphisms in the NAT2 gene, by a polymerase chain reaction (PCR)-based test." | 5.29 | N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. ( Bi, W; Broly, F; Caporaso, N; Feng, P; Hayes, RB; Meyer, UA; Rothman, N; Woosley, RL; Yin, S; You, X, 1993) |
| "For the evaluation of cancer risks associated with immunodeficiencies experienced by patients with Hansen's disease (leprosy) and for the assessment of possible adverse effects of dapsone therapy, a follow-up study was conducted of 1,678 patients admitted to the National Hansen's Disease Center in Carville, La." | 3.67 | Cancer mortality among patients with Hansen's disease. ( Brinton, LA; Fraumeni, JF; Hoover, R; Jacobson, RR, 1984) |
| "Genetically determined polymorphisms of N-acetylation and oxidative capacity have been studied using dapsone and metoprolol in 51 Japanese patients with spontaneous bladder cancer and 203 healthy control subjects." | 3.67 | Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer. ( Fujita, K; Horai, Y; Ishizaki, T, 1989) |
| "Patients with aggressive bladder cancer had a similar distribution but significantly lower mean value (p < 0." | 1.29 | Low activity of dapsone N-hydroxylation as a susceptibility risk factor in aggressive bladder cancer. ( Adedoyin, A; Branch, RA; Fleming, CM; Kaisary, A; Persad, R; Porter, J; Smith, P; Wilkinson, GR, 1994) |
| "Thirty-eight bladder cancer cases and 43 controls from these factories were included for study of acetylation phenotype, by dapsone administration, and for polymorphisms in the NAT2 gene, by a polymerase chain reaction (PCR)-based test." | 1.29 | N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. ( Bi, W; Broly, F; Caporaso, N; Feng, P; Hayes, RB; Meyer, UA; Rothman, N; Woosley, RL; Yin, S; You, X, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brinton, LA | 1 |
| Hoover, R | 1 |
| Jacobson, RR | 1 |
| Fraumeni, JF | 1 |
| Person, JR | 1 |
| Schwartz, JH | 1 |
| Fleming, CM | 1 |
| Persad, R | 1 |
| Kaisary, A | 1 |
| Smith, P | 1 |
| Adedoyin, A | 1 |
| Porter, J | 1 |
| Wilkinson, GR | 1 |
| Branch, RA | 1 |
| Hayes, RB | 1 |
| Bi, W | 1 |
| Rothman, N | 1 |
| Broly, F | 1 |
| Caporaso, N | 1 |
| Feng, P | 1 |
| You, X | 1 |
| Yin, S | 1 |
| Woosley, RL | 1 |
| Meyer, UA | 1 |
| Horai, Y | 1 |
| Fujita, K | 1 |
| Ishizaki, T | 1 |
5 other studies available for dapsone and Bladder Cancer
| Article | Year |
|---|---|
Cancer mortality among patients with Hansen's disease.
Topics: Asian; Black or African American; Dapsone; Female; Hispanic or Latino; Humans; Leprosy; Lymphoma; Ma | 1984 |
Dapsone-responsive, noninfectious verrucous pyoderma. Its occurrence following cisplatin therapy.
Topics: Aged; Cisplatin; Dapsone; Hand Dermatoses; Humans; Male; Pyoderma; Urinary Bladder Neoplasms | 1982 |
Low activity of dapsone N-hydroxylation as a susceptibility risk factor in aggressive bladder cancer.
Topics: Case-Control Studies; Dapsone; Genetic Predisposition to Disease; Humans; Hydroxylation; Inactivatio | 1994 |
N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers.
Topics: Acetylation; Aged; Benzidines; Case-Control Studies; China; Dapsone; Genotype; Humans; Male; Middle | 1993 |
Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer.
Topics: Acetylation; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Dapsone; Disease Susceptibilit | 1989 |